The United States Patent and Trademark Office (USPTO) has issued patent US12584984B2 to Siemens Healthineers AG. This patent covers systems and methods for AI-powered histological fingerprinting, which uses machine learning to analyze magnetic resonance imaging (MR) signal data and ground truth tissue microstructure data. The technology aims to generate a dictionary or train a model to map MR signals to histological parameters, including tissue microstructure, and includes a signal-to-signal translation model for improved sensitivity.

This patent grant represents a new technological development in medical imaging and diagnostics. While it does not impose direct compliance obligations on other entities, it signifies innovation in AI applications within healthcare. Companies operating in the medical device and diagnostic imaging sectors, particularly those developing AI-driven solutions, should be aware of this granted patent as it may impact future product development and intellectual property strategies.